GRAFT-VERSUS-HOST DISEASE: THERAPEUTIC ADVANCES AND THE SHIFTING MARKET DYNAMICS

Graft-Versus-Host Disease: Therapeutic Advances and the Shifting Market Dynamics The Graft-versus-Host Disease (GvHD) market is advancing rapidly as researchers and pharmaceutical companies work to address the complexities of this condition. GvHD, a severe complication following allogeneic stem cell transplantation, occurs when donor immune cell